CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated…
Collaboration will combine Moderna’s mRNA technology with CytomX’s Probody® Platform to generate and develop…
Read More...
Read More...
Browsing Tag
Conditionally
Sensei Biotherapeutics Announces Collaboration with Washington University, St. Louis to Support…
BOSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
Read More...
Read More...
CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b…
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in…
Read More...
Read More...
Sensei Biotherapeutics to Present Preclinical Data for SNS-101, a Conditionally Active…
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
Read More...
Read More...